Results 1 to 10 of about 2,031,710 (98)

Dapagliflozin in Patients with Chronic Kidney Disease.

New England Journal of Medicine, 2020
BACKGROUND Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.
H. Heerspink, B. Stefánsson, R. Correa-Rotter, G. Chertow, T. Greene, F. Hou, J. Mann, J. McMurray, M. Lindberg, P. Rossing, C. Sjöström, R. Toto, A. Langkilde, D. Wheeler   +13 more
semanticscholar   +1 more source

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2022
Background This study, the EMPA-KIDNEY trial, was designed to assess the effects of empagliflozin in a broad range of patients with chronic kidney disease (CKD) at risk of progression. Methods We randomly assigned 6609 participants to empagliflozin (10mg
W. Herrington, N. Staplin, C. Wanner, J. B. Green, S. Hauske, J. Emberson, D. Preiss, P. Judge, Kaitlin J. Mayne, S. Ng, E. Sammons, D. Zhu, M. Hill, W. Stevens, K. Wallendszus, S. Brenner, A. Cheung, Zhi-Hong Liu, Jing Li, L. Hooi, Wen Liu, T. Kadowaki, M. Nangaku, A. Levin, D. Cherney, A. Maggioni, R. Pontremoli, R. Deo, S. Goto, X. Rosselló, K. Tuttle, D. Steubl, M. Petrini, D. Massey, Jens Eilbracht, M. Brueckmann, M. Landray, C. Baigent, R. Haynes   +38 more
semanticscholar   +1 more source

Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance.

JAMA Internal Medicine, 2023
Importance To our knowledge, there has been no update on the prevalence of chronic kidney disease (CKD) in China since 2012. Objective To provide periodic nationwide data on the prevalence of CKD and the associated behavioral and metabolic risk factors
Limin Wang, Xin Xu, Mei Zhang, C. Hu, X. Zhang, Chun Li, S. Nie, Zheng-jing Huang, Zhenping Zhao, F. Hou, Maigeng Zhou   +10 more
semanticscholar   +1 more source

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Diabetes Care, 2022
People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent clinical trials support new approaches to treat diabetes and CKD.
I. D. de Boer, K. Khunti, Tami Sadusky, K. Tuttle, Joshua J. Neumiller, Connie M. Rhee, Sylvia E. Rosas, P. Rossing, G. Bakris   +8 more
semanticscholar   +1 more source

A Machine Learning Methodology for Diagnosing Chronic Kidney Disease

IEEE Access, 2023
Chronic kidney disease (CKD) is a global health problem with high morbidity and mortality rate, and it induces other diseases. Since there are no obvious symptoms during the early stages of CKD, patients often fail to notice the disease.
Jiongming Qin, Lin Chen, Yuhua Liu, Chuanjun Liu, Changhao Feng, Bin Chen   +5 more
semanticscholar   +1 more source

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

New England Journal of Medicine, 2020
BACKGROUND Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and type 2 diabetes.
G. Bakris, R. Agarwal, S. Anker, B. Pitt, L. Ruilope, P. Rossing, P. Kolkhof, C. Nowack, Patrick Schloemer, A. Joseph, G. Filippatos   +10 more
semanticscholar   +1 more source

Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease

Circulation Research, 2023
Hypertension is the leading modifiable cause of premature death and hence one of the global targets of World Health Organization for prevention. Hypertension also affects the great majority of patients with chronic kidney disease (CKD). Both hypertension
M. Burnier, A. Damianaki
semanticscholar   +1 more source

Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

PLoS ONE, 2016
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD).
N. Hill, Samuel T. Fatoba, J. Oke, J. Hirst, C. O'Callaghan, D. Lasserson, F. R. Hobbs   +6 more
semanticscholar   +1 more source

Prediction of Chronic Kidney Disease - A Machine Learning Perspective

IEEE Access, 2022
Chronic Kidney Disease is one of the most critical illness nowadays and proper diagnosis is required as soon as possible. Machine learning technique has become reliable for medical treatment. With the help of a machine learning classifier algorithms, the
Pankaj Chittora, Sandeep Chaurasia, P. Chakrabarti, Gaurav Kumawat, T. Chakrabarti, Zbigniew Leonowicz, M. Jasinski, Łukasz Jasiński, R. Goňo, E. Jasińska, Vadim Bolshev   +10 more
semanticscholar   +1 more source

Cardiovascular Disease in Chronic Kidney Disease

Circulation, 2021
Patients with chronic kidney disease (CKD) exhibit an elevated cardiovascular risk manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac death.
J. Jankowski, J. Floege, D. Fliser, M. Böhm, N. Marx   +4 more
semanticscholar   +1 more source